Puissance Capital Management LP
CIK
1658437
Location
NEW YORK, NY
Portfolio Value
Micro
$1,524,560
Diversification
Highly concentrated
Filing Date
Global Rank
#5,196
/ 5,288
▲ 91
Top Industry
Drug Manufacturers - Specialty & Generic
90.0%
3Y Alpha vs SPY
-0.3%
Period ended 5 years ago
Filed Nov 12, 2020 · 5y
3 quarters · since Mar 2020
Clone Performance
Jun 2023–Jun 2026 · vs SPYHypothetical growth of cloning every reported 13F position and rebalancing on each filing, indexed to the same start.
Cloned portfolio
+75.1%
SPY
+76.3%
Annualised alpha
-0.3%
Max drawdown
−73.0%
Estimate. 13F holdings are quarter-lagged and long-only, so the clone rebalances about 45 days after each period end — when the filing becomes public — and excludes options and short positions. Past performance does not predict future results.
Portfolio Concentration
2 positions · as of Sep 30, 2020 · Δ vs Jun 30, 2020Top Position
90.0%
−10.0 pts
Top 5
100.0%
0.0 pts
Top 10
100.0%
0.0 pts
HHI
8,200
Highly concentrated−1,800
Portfolio Trend
3 quarters · across all stocks
Sector Breakdown
As of Sep 30, 2020| Sector | % Portfolio | Value |
|---|---|---|
| Healthcare | 100.0% | $1,524,560 |
Last Quarter's Activity
Export CSVAdded To
Positions the filer increasedNo qualifying positions this quarter.
Trimmed
Positions the filer reducedNo qualifying positions this quarter.
New Positions
Positions the filer opened this quarter
1 positions
| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| SCYX | Scynexis Inc | 311,143 | $1,372,140 | |
| No positions match the current search. | ||||
Sold Out
Positions the filer fully exitedNo qualifying positions this quarter.
2 positions ·
$1,524,560 total
· as of Sep 30, 2020
| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| SCYX |
Scynexis Inc
Healthcare
|
NEW | 311,143 | $1,372,140 | 90.00% | |
| CRVS |
Corvus Pharmaceuticals, Inc.
Healthcare
|
Held | 38,010 | $152,420 | 10.00% |